# A Clinical Study of Albumin-bound Paclitaxel/Granulocyte-based Therapy for Recurrent/Metastatic Breast Cancer

> **NCT06496724** · NA · RECRUITING · sponsor: **JIANG LONGWEI** · enrollment: 1 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** Albumin paclitaxel/neutrophil drug

## Key facts

- **NCT ID:** NCT06496724
- **Lead sponsor:** JIANG LONGWEI
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-07-01
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06496724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06496724, "A Clinical Study of Albumin-bound Paclitaxel/Granulocyte-based Therapy for Recurrent/Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06496724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*